Envoy Medical, Inc. (COCH): debt financing — Envoy Medical draws remaining $5M from GAT Funding; issues warrant for 750K shares at $1.48

Envoy Medical, Inc.

Drew $5M remaining principal under March 2025 note from GAT Funding, controlled by board member Glen Taylor.
Issued warrant for 750,000 shares of Class A common at $1.48/share closing price, exercisable for two years.
Warrant issued as commitment fee for draw; transaction is a related-party financing.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Envoy Medical, Inc. incurred loan of $5,000,000 with GAT Funding, LLC.

Instrument: loan
Principal: $5,000,000
Counterparty: GAT Funding, LLC
Event: incurrence

Exact text from the filing

On June 26, 2025, Envoy Medical, Inc. (the “Company”) drew the remaining $5,000,000 of available principal under the promissory note, dated as of March 6, 2025 (the “Note”), between the Company and GAT Funding, LLC (“GAT”).

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-061057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.